Search

Now showing items 1-10 of 14

IgA antibodies against deamidated gliadin peptides in patients with chronic liver diseases

Gatselis, N. K.; Zachou, K.; Norman, G. L.; Tzellas, G.; Speletas, M.; Gabeta, S.; Germenis, A.; Koukoulis, G. K.; Dalekos, G. N. (2012)

Background/aims: IgA antibodies against tissue-transglutaminase (anti-tTG-IgA) and IgA and IgG antibodies against deamidated gliadin peptides (anti-DGP-IgA and anti-DGP-IgG) are considered specific for celiac disease (CD) ...

Cartilage oligomeric matrix protein: A novel non-invasive marker for assessing cirrhosis and risk of hepatocellular carcinoma

Norman, G. L.; Gatselis, N. K.; Shums, Z.; Liaskos, C.; Bogdanos, D. P.; Koukoulis, G. K.; Dalekos, G. N. (2015)

AIM: To assess serum cartilage oligomeric matrix protein (COMP) as a marker of cirrhosis and risk of progression to hepatocellular carcinoma (HCC). METHODS: A COMP enzyme-linked immunosorbent assay was used to test 187 ...

Chronic hepatitis C is characterised by an interferon-alpha induced novel autoantibody giving a crescent pattern by indirect immunofluorescence

Liaskos, C.; Bogdanos, D. P.; Gatselis, N.; Horner, D.; Shums, Z.; Murphy, D.; Rigopoulou, E. I.; Smith, H.; Vergani, D.; Norman, G. L.; Dalekos, G. N. (2007)

Cartilage oligomeric matrix protein (COMP) serum levels: a new non-invasive biomarker of liver fibrosis in patients with chronic viral hepatitis

Gabeta, S.; Zachou, K.; Shums, Z.; Gatselis, N.; Koukoulis, G. K.; Norman, G. L.; Dalekos, G. N. (2014)

CLINICAL SIGNIFICANCE OF THE FLUCTUATION OF PRIMARY BILIARY CIRRHOSIS-RELATED AUTOANTIBODIES DURING THE COURSE OF THE DISEASE

Gatselis, N. K.; Zachou, K.; Norman, G. L.; Gabeta, S.; Koukoulis, G. K.; Dalekos, G. N. (2012)

IgA isotype specific anti-b2GPI antibodies in patients with autoimmune liver diseases

Gabeta, S.; Norman, G. L.; Gatselis, N.; Liaskos, C.; Papamichalis, P. A.; Garagounis, A.; Zachou, K.; Rigopoulou, E. I.; Dalekos, G. N. (2008)

IGA ANTIBODIES AGAINST DEAMIDATED GLIADIN PEPTIDES AND TISSUE-TRANSGLUTAMINASE IN PATIENTS WITH CHRONIC LIVER DISEASES

Gatselis, N. K.; Zachou, K.; Norman, G. L.; Tzelas, G.; Gabeta, S.; Speletas, M.; Koukoulis, G. K.; Dalekos, G. N. (2012)

Antibody responses specific for soluble liver antigen co-occur with RO-52 autoantibodies in patients with autoimmune hepatitis

Liaskos, C.; Bogdanos, D. P.; Rigopoulou, E. I.; Norman, G. L.; Shurns, Z.; Al-Chalabi, T.; Krawitt, E. L.; Mieli-Vergani, G.; Czaja, A. J.; Vergani, D.; Dalekos, G. N. (2007)

Cartilage oligomeric matrix protein (COMP): A novel non-invasive marker for assessing liver cirrhosis and risk of progression to hepatocellular carcinoma

Norman, G. L.; Gatselis, N.; Shums, Z.; Liaskos, C.; Bogdanos, D. P.; Koukoulis, G. K.; Dalekos, G. N. (2014)

Diagnostic relevance and clinical significance of the new enhanced performance M2 (MIT3) ELISA for the detection of IgA and IgG antimitochondrial antibodies in primary biliary cirrhosis

Gabeta, S.; Norman, G. L.; Liaskos, C.; Papamichalis, P. A.; Zografos, T.; Garagounis, A.; Rigopoulou, E. I.; Dalekos, G. N. (2007)

Background/aims: Antimitochondrial antibodies (AMAs) are the serological hallmark of primary biliary cirrhosis (PBC). We evaluated the sensitivity and specificity of a new M2 enhanced performance enzyme-linked immunosorbent ...